by Mollie McDowell | Apr 14, 2014 | Rock Weekly
In case you missed the news last week, our portfolio companies dominated the funding charts, including drchrono, Wellframe, and Andreessen Horowitz’s first major health investment — Omada Health. However, Beltway Insiders had a particularly rough week. HHS got a new...
by Guest Contributor | Apr 10, 2014 | Other
Dr. Bonnie Feldman How would you feel if, after years of searching for a diagnosis you finally found out you have an autoimmune disease, and then you realize that your doctors will have to experiment on you to find the right treatment? That’s the state of the art...
by Sonia Havele | Apr 9, 2014 | Other
Photo courtesy of Haas School of Business Several weeks ago, we journeyed over to San Francisco’s Hotel Nikko for the 8th Annual Haas Business of Healthcare Conference, presented by UC Berkeley Haas School of Business. This year’s theme, “Exploring New...
by Halle Tecco | Apr 9, 2014 | Portfolio News
The Rock Health team is proud to announce that portfolio company Omada Health has just closed their $23M Series B (full press release here) from Andreessen Horowitz and Kaiser Permanente Ventures. I first met with the Omada co-founders three years ago when they were...
Recent Comments